- £22.13m
- £27.96m
- $28.65m
REG - Tissue Regenix Group - Result of AGM
AnnouncementREG - Tissue Regenix Group - Grant of share options
AnnouncementREG - Tissue Regenix Group - Posting of Annual Report & Notice of AGM
AnnouncementREG - Tissue Regenix Group - Final results for the year ended 31 December 2024
AnnouncementREG - Tissue Regenix Group - CE & UKCA certification for OrthoPure® XT
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Tissue Regenix Group - Conclusion of Strategic Review & Offer Period
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Tissue Regenix Group - European patent granted
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5- Tissue Regenix Group Plc
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Cavendish Securities Tissue Regenix Group - Form 8.5 (EPT/NON-RI)
Announcement